357 related articles for article (PubMed ID: 24857067)
1. Ampullary cancer: an overview.
Ahn DH; Bekaii-Saab T
Am Soc Clin Oncol Educ Book; 2014; ():112-5. PubMed ID: 24857067
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of Ampullary Adenocarcinoma].
Shin DW
Korean J Gastroenterol; 2023 Oct; 82(4):159-170. PubMed ID: 37876255
[TBL] [Abstract][Full Text] [Related]
3. Predictors of survival in periampullary cancers following pancreaticoduodenectomy.
Hatzaras I; George N; Muscarella P; Melvin WS; Ellison EC; Bloomston M
Ann Surg Oncol; 2010 Apr; 17(4):991-7. PubMed ID: 20108122
[TBL] [Abstract][Full Text] [Related]
4. 15-year experience with surgical treatment of duodenal carcinoma: a comparison of periampullary and extra-ampullary duodenal carcinomas.
Onkendi EO; Boostrom SY; Sarr MG; Farnell MB; Nagorney DM; Donohue JH; Kendrick ML; Reid-Lombardo KM; Harmsen WS; Que FG
J Gastrointest Surg; 2012 Apr; 16(4):682-91. PubMed ID: 22350721
[TBL] [Abstract][Full Text] [Related]
5. Distribution and pathological features of pancreatic, ampullary, biliary and duodenal cancers resected with pancreaticoduodenectomy.
Chandrasegaram MD; Chiam SC; Chen JW; Khalid A; Mittinty ML; Neo EL; Tan CP; Dolan PM; Brooke-Smith ME; Kanhere H; Worthley CS
World J Surg Oncol; 2015 Feb; 13():85. PubMed ID: 25890023
[TBL] [Abstract][Full Text] [Related]
6. Ampullary and periampullary adenocarcinoma: new challenges in management of recurrence.
Ramfidis VS; Syrigos KN; Saif MW
JOP; 2013 Mar; 14(2):158-60. PubMed ID: 23474562
[TBL] [Abstract][Full Text] [Related]
7. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
[TBL] [Abstract][Full Text] [Related]
8. Longterm survival after pancreaticoduodenectomy for periampullary adenocarcinomas.
Chen SC; Shyr YM; Wang SE
HPB (Oxford); 2013 Dec; 15(12):951-7. PubMed ID: 23472708
[TBL] [Abstract][Full Text] [Related]
9. Ampullary Cancer.
Zheng-Pywell R; Reddy S
Surg Clin North Am; 2019 Apr; 99(2):357-367. PubMed ID: 30846039
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of prognosis-associated factors in pancreatic head and peri-ampullary cancer].
Roder JD; Siewert JR
Chirurg; 1992 May; 63(5):410-5. PubMed ID: 1376655
[TBL] [Abstract][Full Text] [Related]
11. Very early recurrence following pancreaticoduodenectomy in patients with ampullary cancer.
Park HM; Park SJ; Han SS; Hong SK; Hong EK; Kim SW
Medicine (Baltimore); 2019 Nov; 98(44):e17711. PubMed ID: 31689805
[TBL] [Abstract][Full Text] [Related]
12. Current strategies in the therapeutic approach for adenocarcinoma of the ampulla of Vater.
Gaspar B; Beuran M; Paun S; Ganescu R; Hostiuc S; Negoi I
J Med Life; 2013 Sep; 6(3):260-5. PubMed ID: 24146684
[TBL] [Abstract][Full Text] [Related]
13. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation.
Tsao JI; Rossi RL; Lowell JA
Arch Surg; 1994 Apr; 129(4):405-12. PubMed ID: 7908796
[TBL] [Abstract][Full Text] [Related]
14. Survival after resection of ampullary carcinoma: a national population-based study.
O'Connell JB; Maggard MA; Manunga J; Tomlinson JS; Reber HA; Ko CY; Hines OJ
Ann Surg Oncol; 2008 Jul; 15(7):1820-7. PubMed ID: 18369675
[TBL] [Abstract][Full Text] [Related]
15. Underutilization of Surgery in Periampullary Cancer Treatment.
Michalski CW; Liu B; Heckler M; Roth S; Sun H; Heger U; Büchler MW; Hackert T
J Gastrointest Surg; 2019 May; 23(5):959-965. PubMed ID: 30088190
[TBL] [Abstract][Full Text] [Related]
16. Periampullary adenocarcinoma: analysis of 5-year survivors.
Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Lillemoe KD; Pitt HA
Ann Surg; 1998 Jun; 227(6):821-31. PubMed ID: 9637545
[TBL] [Abstract][Full Text] [Related]
17. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of intratumoural microvessel density (IMD) in resected pancreatic and ampullary cancers to standard histopathological variables and survival.
Khan AW; Dhillon AP; Hutchins R; Abraham A; Shah SR; Snooks S; Davidson BR
Eur J Surg Oncol; 2002 Sep; 28(6):637-44. PubMed ID: 12359201
[TBL] [Abstract][Full Text] [Related]
19. Duodenal, ampullary, and pancreatic neuroendocrine tumors: Oncologic outcomes are driven by tumor biology and tissue of origin.
Schmocker RK; Wright MJ; Ding D; Javed AA; Cameron JL; Lafaro K; Burns WR; He J; Wolfgang CL; Burkhart RA
J Surg Oncol; 2021 Feb; 123(2):416-424. PubMed ID: 33125737
[TBL] [Abstract][Full Text] [Related]
20. [Current indications for pylorus saving duodenopancreatic head resection in malignancy].
Reith HB; Kozuschek W; Traverso LW
Langenbecks Arch Chir; 1996; 381(4):207-11. PubMed ID: 8965594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]